Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H8O3 |
Molecular Weight | 152.1473 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)OC1=CC=C(O)C=C1
InChI
InChIKey=HBMCQTHGYMTCOF-UHFFFAOYSA-N
InChI=1S/C8H8O3/c1-6(9)11-8-4-2-7(10)3-5-8/h2-5,10H,1H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/26241392
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26241392
Hydroquinone monoacetate (also known as 4-acetoxyphenol), an FDA-approved natural compound, was studied as a potent activator of the NRF2-ARE pathway in motor neurons and as a α-synuclein modulator that can possibly prevent or slow down the onset or progression of Parkinson's disease. In addition, was evaluated the role of 4-acetoxyphenol in age-related macular degeneration (AMD), a degenerative disorder of the central retina, which is the leading cause of irreversible central vision loss in elderly populations in developed countries. It was shown, that 4-acetoxyphenol protected human retina pigment epithelium cell lines from oxidative stress-induced necrosis through upregulation of NQO1 and HO-1 genes by stabilization of NRF2, a transcription factor and a master regulator of many antioxidant/detoxification genes. Thus, 4-Acetoxyphenol could be further evaluated for its potential use in preventing AMD progression.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Conversion of 4-hydroxyacetophenone into 4-phenyl acetate by a flavin adenine dinucleotide-containing Baeyer-Villiger-type monooxygenase. | 2000 Dec |
|
A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation. | 2001 |
|
4-Hydroxyacetophenone monooxygenase from Pseudomonas fluorescens ACB. A novel flavoprotein catalyzing Baeyer-Villiger oxidation of aromatic compounds. | 2001 May |
|
Measurement of ambient hydroperoxides using an automated HPLC system and various factors which affect variations of their concentrations in Korea. | 2008 Dec |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26241392
The NRF2 is a transcription factor that protects against oxidative stress by binding to the antioxidant response element (ARE) in the promoter of its target genes, including NQO1 and HO-1. It was studied whether NRF2 activity is regulated by 4-Acetoxyphenol (4-AC) in human retina pigment epithelium cell lines (ARPE-19) by examining its effect on ARE activity using luciferase reporter assay. Pretreatment with 5 μM 4-AC for 24 hours induced a significant increase in luciferase activity by 2.7 ± 0.6-fold, indicating activation of NRF2 transcription factor. NRF2 mRNA level was not affected by 4-AC, measured by (q)RT-PCR, suggesting 4-AC functions at the NRF2 protein level. Normally, NRF2 is localized in the cytoplasm of ARPE-19 cells. Treatment with 200 μM tBHP for 30 minutes only occasionally induced the translocation of NRF2 to the nucleus. Pretreatment with 5 μM 4-AC for 24 hours resulted in robust translocation of NRF2 to the nucleus with or without induction of oxidative stress. There was also examined the NRF2 stability in response to 4-AC treatment. The half-life of the NRF2 in ARPE-19 cells in the presence of 4-AC was evaluated by Western blot. The amount of NRF2 was decreased to approximately 25% after treatment with cycloheximide for 30 minutes. However, pretreatment with 4-AC significantly extended NRF2 protein half-life, as approximately 96% of NRF2 protein was detected at 30 minutes and approximately 83% of NRF2 protein was detected at 45 minutes after cycloheximide treatment
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3233-32-7
Created by
admin on Sat Dec 16 06:50:10 GMT 2023 , Edited by admin on Sat Dec 16 06:50:10 GMT 2023
|
PRIMARY | |||
|
DTXSID70186062
Created by
admin on Sat Dec 16 06:50:10 GMT 2023 , Edited by admin on Sat Dec 16 06:50:10 GMT 2023
|
PRIMARY | |||
|
47899
Created by
admin on Sat Dec 16 06:50:10 GMT 2023 , Edited by admin on Sat Dec 16 06:50:10 GMT 2023
|
PRIMARY | |||
|
6GIM3882KV
Created by
admin on Sat Dec 16 06:50:10 GMT 2023 , Edited by admin on Sat Dec 16 06:50:10 GMT 2023
|
PRIMARY | |||
|
31128
Created by
admin on Sat Dec 16 06:50:10 GMT 2023 , Edited by admin on Sat Dec 16 06:50:10 GMT 2023
|
PRIMARY | |||
|
96009
Created by
admin on Sat Dec 16 06:50:10 GMT 2023 , Edited by admin on Sat Dec 16 06:50:10 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD